Farampator is an investigational ampakine drug currently under evaluation for potential therapeutic applications in the treatment of neurological disorders, such as epilepsy and Alzheimer's disease. As… Read more
Farampator is an investigational ampakine drug currently under evaluation for potential therapeutic applications in the treatment of neurological disorders, such as epilepsy and Alzheimer's disease. As a synthetic compound that acts as a positive allosteric modulator of AMPA receptors, its development requires precise analytical oversight to ensure safety and efficacy. This category includes high-quality reference standards and stable isotope labelled compounds, such as Farampator-d10, which are essential for rigorous scientific research. Pharmaceutical and analytical laboratories utilize these materials for accurate impurity profiling, method validation, and metabolic pathway tracing. By providing consistent and reliable reference materials, these compounds support critical quality control processes during preclinical and clinical testing, ensuring the integrity of data when quantifying levels of the parent drug and its related impurities in complex matrices.